IMCD acquires Latin American Blumos Group to accelerate life science markets growth

IMCD acquires Latin American Blumos Group to accelerate life science markets growth

By: ICN Bureau

Last updated : October 20, 2024 6:45 pm



Blumos Group distributes a comprehensive portfolio of specialty ingredients and chemicals for the food, pharmaceutical, and industrial markets across Latin America


IMCD N.V. (IMCD), a global leading distributor of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Importadora y Distribuidora Blumos SpA, Transportes Blumos SpA, Comercial e Industrial Solutec SpA, all in Chile, Sonutra Blumos SAC in Peru and Blumos S.A. in Argentina (Blumos Group).

Established in 1945 and headquartered in Santiago, Chile and with operations also in Peru and Argentina, Blumos Group distributes a comprehensive portfolio of specialty ingredients and chemicals for the food, pharmaceutical, and industrial markets across Latin America.

“The Blumos Group is a perfect cultural and strategic fit with IMCD. Through the strong and complementary supplier and customer relationships fostered by Blumos over the years, IMCD is poised to further expand its business in Latin America” said Nicolas Kaufmann, Latin America President, IMCD.

“Blumos has built a legacy of almost 80 years distributing specialty chemicals, and is also recognized as a leading solution-provider for clients in the region. IMCD is the perfect partner to help continue our growth. Our pursuit of excellence and commitment to innovation fit very well with IMCD’s values. This partnership will help our team to provide even more comprehensive solutions for our customers. We are very pleased and excited to join IMCD,” comments Roberto Blum, CEO and founder of Blumos Group.

The closing of the transaction is subject to customary (regulatory) closing conditions and is expected to take place in the fourth quarter of 2024.

IMCD N.V. IMCD Importadora y Distribuidora Blumos SpA Transportes Blumos SpA Comercial e Industrial Solutec SpA Nicolas Kaufmann Roberto Blum speciality chemicals ingredients

First Published : October 20, 2024 12:00 am